Study of NANOKINE vs Eprex in healthy men
This study tests a new experimental drug called NANOKINE alongside an approved drug (Eprex) to see how your body handles them. It is for healthy male volunteers and will help researchers understand how the new drug works and if it is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a male between 18 and 45 years old.
- You weigh between 50 and 70 kg (110 to 154 pounds).
- You are generally healthy, with no chronic illnesses or recent serious infections.
- You have not used any drugs that boost red blood cell production (like Procrit or Epogen) in the last 3 months.
- You have not donated blood or lost more than 450 mL of blood in the last 28 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new erythropoietin (a medicine that helps your body make red blood cells) and compares it to an approved version called Eprex. It is for healthy adults to see how the two medicines work in the body and if they are safe.
This study tests a new drug called Efepoetin Alfa to treat anemia in people with chronic kidney disease who are on dialysis. The goal is to see if it can safely raise red blood cell levels and reduce the need for other anemia treatments.
This Phase 1 study tests how an injected “copy” version of erythropoietin behaves in the blood in healthy volunteers. It’s mainly about measuring safety and blood-level changes, not treating an illness.
This study tests two medicines (daprodustat and epoetin alfa) to see which one works better for treating low red blood cell counts (anemia) in people with chronic kidney disease who are not on dialysis yet. Both medicines aim to increase hemoglobin and reduce fatigue.
This trial tests two similar medicines that help your body make red blood cells. It is for people with advanced chronic kidney disease who are on dialysis, and aims to see if the study medicine works as well as the standard one.
This study tests a new medicine called NKF-PEG, which is similar to Neulasta (a drug that helps boost white blood cells after chemotherapy). It is being tested in healthy men to see how the body processes it and to check for side effects.
Hear when a new Pharmacokinetics and Pharmacodynamics in Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.